Adaptive Biotechnologies Corp. | Company Profile - Revenue, Headcount, Tech Stack, Contacts
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Social & Marketing
Email & Communication
Keywords & Focus Areas
Adaptive Biotechnologies Corp.
Overview
Adaptive Biotechnologies Corporation is a biotechnology company founded in 2009 by brothers Harlan and Chad Robins. The company specializes in immune medicine, focusing on developing diagnostics, research tools, and therapeutics for diseases such as cancer, autoimmune disorders, and infectious diseases. They utilize proprietary immunosequencing technology to analyze T-cell and B-cell receptor genes, enabling precise profiling at scale.
The company's key offerings include the immunoSEQ Platform, which features assays for TCR and B-cell receptor profiling, and the clonoSEQ Assay, a next-generation sequencing method for detecting minimal residual disease in blood-based tumors. Adaptive also provides pharma services and drug discovery support, leveraging immune receptor data for clinical trials and personalized cancer therapeutics. Their tools for immune profiling and diagnostics facilitate early disease detection from blood samples, contributing to advancements in clinical practice and transformative medicines. The company collaborates with various academic and strategic partners, including a notable alliance with Microsoft to enhance data management and AI capabilities in their research.
Basic Information
| Industry | biotechnology |
|---|---|
| Founded | 2009 |
| Revenue | 179.0M |
| Headquarters | 1165 Eastlake Ave E, Seattle, Washington 98109-4456, United States |
| Languages | English |
| Alexa Ranking | 404,363 |
Contact Details
- Phone: +1 855-466-8667
- Website: adaptivebiotech.com
- LinkedIn: linkedin.com/company/adaptive-biotechnologies-corp-
Key Focus Areas & Initiatives
- Immune medicine
- Diagnostics for cancer, autoimmune disorders, and infectious diseases
- Proprietary immunosequencing technology
- T-cell and B-cell receptor gene profiling
- immunoSEQ Platform
- clonoSEQ Assay for minimal residual disease detection
- Pharma services and drug discovery support
- Immune receptor data for clinical trials
- Early disease detection from blood samples
- Collaboration with Microsoft for AI and data management
Technologies Used
- AI
- API Gateway
- Act!
- Amazon AWS
- Atlassian Cloud
- Azure Active Directory
- Azure Key Vault
- Benchling
- Camunda
- ChatGPT
- Confluence
- Docker
- ETQ Reliance QMS
- Epic
- GitHub Copilot
- GitLab
- Google AdWords Conversion
- Google Font API
- Google Tag Manager
- Greenhouse.io
- JFrog
- Javascript
- LabWare LIMS
- Later
- LaunchDarkly
- Liquid
- Micro
- Microsoft Active Directory Federation Services
- Microsoft Azure Monitor
- Microsoft Excel
- Microsoft PowerPoint
- Microsoft PowerShell
- Mobile Friendly
- New Relic
- Nginx
- Office365
- Okta
- OneTrust
- OpenLDAP
- Outlook
- Pantheon
- Pardot
- Postman
- REST
- Remedy Single Sign On
- Remote
- SAM
- SAP Crystal Solutions
- SQL
- Salesforce
- Slack
- Smartsheet
- Tableau
- Tor
- Varnish
- Verizon WAF
- VueJS
- Wistia
- WordPress.org
- reCAPTCHA
Community
